Sökning: "contralateral breast cancer"
Visar resultat 1 - 5 av 12 avhandlingar innehållade orden contralateral breast cancer.
1. Predicting Prognosis and Tamoxifen Response in Breast Cancer. With a special focus on contralateral breast cancer
Sammanfattning : One of the great challenges in breast cancer treatment today is to customize adjuvant treatment to each patient’s individual needs. To do this it is necessary to learn more about the prognostic and treatment predictive factors that determine the risk of relapse and response to a certain mode of treatment. LÄS MER
2. Breast cancer in young women. Aspects of heredity and contralateral disease
Sammanfattning : Breast cancer is the most commonly diagnosed cancer among women in Sweden, as well as worldwide. In Sweden, 8,288 women were diagnosed with invasive breast cancer in 2019, out of whom approximately 1.5% were younger than 35 years of age. LÄS MER
3. Long-term effects of adjuvant tamoxifen treatment on cardiovascular disease and cancer
Sammanfattning : The aims of this thesis were to investigate the long-term effects of adjuvant tamoxifen treatment on breast cancer recurrence and mortality, cardiovascular disease, and the incidence of secondary cancer.Between 1982 and 1992, postmenopausal patients with early stage breast cancer were included in a randomized clinical study of 2 or 5 years of postoperative tamoxifen therapy. LÄS MER
4. Breast Cancer Biomarkers with Clinical Relevance Identified by Massively-parallel DNA and RNA Sequencing
Sammanfattning : Women have a 10% lifetime risk of developing breast cancer, and the disease has surpassed lung cancer as the most frequently diagnosed type of cancer in the world. Breast cancer originates in the epithelial cells of the mammary gland and tumor cells have undergone a series of genetic and phenotypic changes that confer tumor promoting properties. LÄS MER
5. The Value of Preoperative MRI in Breast Cancer Treatment
Sammanfattning : Breast magnetic resonance imaging (MRI) remains controversial as an image adjunct in preoperative settings in terms of short-term benefits and there are no survival data from randomized studies. This prospective, randomized, multicentre study included 440 patients (age ≤ 56 y) with breast cancer from three large-volume Swedish breast clinics. LÄS MER